Consano Bio
Private
Consano Bio is a clinical-stage biotechnology company advancing novel therapeutics designed to address serious, painful orthopedic conditions. Recently received FDA IND clearance to expand its C-1101 chronic sciatica clinical development program into the United States.
Company Info
Upcoming Milestones & Key Dates
Q4 2026
Clinical
US clinical site activation
Clinical Development Pipeline
C-1101
Target: TBDUndisclosed
Target: TBDUndisclosed
Target: TBDRecent News
No recent news updates available for this company.
Leadership Team
To be confirmed
Chief Executive Officer
To be confirmed
Chief Medical Officer
To be confirmed
Chief Scientific Officer
Careers & Job Openings